Research associated with Bioethics

Publications:

The potential impact of decision role and patient-age on end-of-life treatment decision making.
Zikmund-Fisher BJ, Lacey HP, Fagerlin A. Journal of Medical Ethics. 34:327-31, 2008.

Ethics of sham surgery: Perspective of patients.
Frank S, Holloway RG, Zimmerman C, Peterson DR, Kieburtz K, Kim S. Movement Disorders . In Press, 2007.

Conflicts of interest and the physician-patient relationship in the era of direct-to-patient advertising.
Jagsi R. Journal of Clinical Oncology. 25:902-905, 2007.

Assessing and communicating risks and benefits of gene transfer clinical studies.
Kim S. Current Opinion in Molecular Therapeutics. 8:384-389, 2006.

The capacity to appoint a proxy and the possibility of concurrent proxy directives.
Kim S, Appelbaum PS. Behavioral Sciences and the Law . 24:469-478, 2006.

Do clinicians follow a risk-sensitive model of capacity determination? An experimental video survey.
Kim S, Caine ED, Swan JG, Appelbaum PS. Psychosomatics . 47:325-329, 2006.

Who decides? Living donor liver transplantation for hepatocellular carcinoma.
Ubel PA. Transplantation. 82:1136-1139, 2006.

Context Changes Choices: A Prospective Study of the Effects of Hospitalization on Life-Sustaining Treatment Preferences.
Ditto PH, Jacobson JA, Smucker WD, Danks JH, Fagerlin A. Medical Decision Making. 26:313-322, 2006.

Volunteering for early phase gene transfer research in Parkinson's disease.
Kim S, Holloway RG, Frank S, Beck CA, Zimmerman C, Wilson R, Kieburtz K. Neurology. 66:1010-1015, 2006.

Competency for creation, use, and revocation of psychiatric advance directives.
Srebnik DS, Kim S. Journal of the American Academy of Psychiatry Law. 34:501-510, 2006.

What do people at risk for Alzheimer's disease think about surrogate consent for research?
Kim S, Kim HM, McCallum C, Tariot PN. Neurology. 65:1395-1401, 2005.

Is psychiatric research stigmatized? An experimental survey of the public.
Muroff JR, Hoerauf SL, Kim S. Schizophrenia Bulletin. 32:129-136, 2005.

When does decisional impairment become decisional incompetence? Ethical and methodologial issues in capacity research in schizophrenia.
Kim S. Schizophrenia Bulletin. 32:92-97, 2005.

Science and ethics of sham surgery: A survey of Parkinson disease clinical researchers.
Kim S, Frank S, Holloway RG, Zimmerman C, Wilson R, Kieburtz K. Archives of Neurology . 62:1357-1360, 2005.

What is the risk of sham surgery in Parkinson's disease clinical trials? A review of published reports.
Frank S, Kieburtz K, Holloway RG, Kim S. Neurology. 65:1101-1103, 2005.

The ability of people with Alzheimer disease (AD) to make a decision about taking an AD treatment.
Karlawish JHT, Kim S, Casarett DJ, James BD, Xie S. Neurology. 64:1514-1519, 2005.

The dilemma of hidden ethical dilemmas.
Kim S. Academic Psychiatry. 28:168-169, 2004.

The ethics of medical education.
Jagsi R, Lehmann LS. British Medical Journal . 329:332-334, 2004.

Evidence-based ethics in neurology and psychiatry research.
Kim S. NeuroRx. 1:372-377, 2004.

Enough: The failure of the living will.
Fagerlin A, Schneider CE. Hastings Center Report. 34:30-42, 2004.

Potential research participants' views regarding researcher and institutional financial conflicts of interest.
Kim S, Millard RW, Nisbet P, Cox C, Caine ED. Journal of Medical Ethics. 30:73-79, 2004.

Benefits and burdens of placebos in psychiatric research.
Kim S. Psychopharmacology . 171:13-18, 2003.

Burdens and benefits of placebos in antidepressant clinical trials: A decision and cost-effectiveness analysis.
Kim S, Holloway RG. American Journal of Psychiatry . 160:1272-1276, 2003.

The sham surgery debate and the moral complexity or risk-benefit analysis.
Kim S. American Journal of Bioethics. 3:66-68, 2003.

Press Coverage:

No information found.